Endogenous cannabinoids mediate hypotension after experimental myocardial infarction.
about
The endocannabinoid system as an emerging target of pharmacotherapyPharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicityPresynaptic cannabinoid CB(1) receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed ratsStress regulates endocannabinoid-CB1 receptor signaling.CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction.CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis.Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats.Endocannabinoids in liver disease.Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation.Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities.Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling.Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusionsBlood pressure regulation by endocannabinoids and their receptorsThe therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors.The peripheral cannabinoid receptor knockout mice: an update.Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioningEndocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats.Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.Cardiovascular pharmacology of cannabinoids.Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors.Endocannabinoids in cerebrovascular regulation.CB1 cannabinoid receptor inhibition: promising approach for heart failure?Endocannabinoids and cardiac contractile function: pathophysiological implications.Endocannabinoids and the heart.The emerging role of the endocannabinoid system in cardiovascular disease.The potential for clinical use of cannabinoids in treatment of cardiovascular diseases.Endocannabinoids and the cardiovascular response to stress.Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection.Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells.Evolving the concept of regulation of vascular tone in humans.Activation of Endocannabinoid Receptor 2 as a Mechanism of Propofol Pretreatment-Induced Cardioprotection against Ischemia-Reperfusion Injury in RatsAcute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious ratsEndocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction?Mechanism of platelet activation induced by endocannabinoids in blood and plasma.Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice.Involvement of CB1-receptors and beta-adrenoceptors in the regional hemodynamic responses to lipopolysaccharide infusion in conscious rats.Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages.The endocannabinoid system in cardiovascular function: novel insights and clinical implications.
P2860
Q24648473-C3106909-3DD9-4574-9175-EC0900E4A47AQ24648835-2F69F26E-85C2-4AFD-97D3-B34A4CD0271FQ28263081-495ACAC0-F505-4450-BA61-CE4DFB1E3F2EQ30402136-092DEE08-1EE9-4264-999C-F9EC0011F6A6Q30918735-906610FF-4EA5-4A18-A122-2A55AC092475Q33488512-449D4B79-0ECD-4F10-9560-8EED212B46ECQ34718182-9AC8F8CD-9D6F-4E99-9F17-5D8C45C99A81Q34776919-1D9FF891-F3D9-4517-8D44-BE9B19573146Q35049157-5601A868-1BAD-40BB-B0EA-AC77826DC2D8Q35228889-B7D68CA0-AC85-47C0-B2EA-4C32617A835BQ35684044-5F9BD662-8F69-48A1-BB18-77F41BA7A4F4Q36052772-1386961A-8175-4272-BDF3-849C7D498195Q36135785-96DFC1F3-1F98-4EF3-B03D-18FB41B88DDDQ36341688-F7C3144A-FD00-4FBE-BE5C-6E17B9DE0FB2Q36407318-C9F9BFCD-2799-429D-A7A3-1C40103E0F46Q36416347-EACAA763-0F8D-4134-A2FE-5C9F723583E8Q36416372-11D631FA-D51F-4525-8D99-64F41A4DA1D2Q36426811-833CA86B-7F23-4605-AD3E-8B4559ACB4D5Q36426831-46B24606-E0A1-4403-BB51-5862091A23DFQ36431860-50E210E8-2855-4D6E-B8DF-F662D5F6F08DQ36802414-085770DE-FA1F-4EAB-BC7F-D9DF1C569C02Q36891652-7620EF9C-ECFA-450C-ACAC-2B1B8BC656CAQ36895795-B4C09CF9-5BA4-4977-BED1-19C1CFB75518Q37160279-7E4B5228-10FB-474B-B238-A8C65FDF8BF6Q37401757-9ED043ED-03A1-43EB-99BA-F5B9F9E6A783Q37412217-7648B815-79CB-4E7F-8F31-8809A0623D50Q37439386-1D9A4E6C-45F4-4BC0-91C6-E950C73CA001Q37800142-29E29EDB-B311-4DA4-8D57-6753FC629FA7Q37894978-8239CBC1-3BF6-4067-BF96-B98BE1124C61Q38135915-B6F8AB9A-6027-4F87-96E5-C5AF344DE252Q39959642-4E622450-415D-4D74-971A-B8906F1DC9B9Q40401804-9E8CDCE2-D649-4874-80EA-8FA0ECDBD7B6Q41320036-DE525670-A3C5-43AA-9A14-42AFA8F11AC4Q41422411-40682F40-C0AA-467E-9592-0F56EE0F0BADQ43263467-A546E0AA-BF76-47BE-B226-8C46C2AAD6ECQ44500279-2BF61C6B-AA99-4024-835C-AE39BF0F14C6Q44879651-B22ADFAF-D75E-4E4E-A516-1B208D3B28CEQ45190193-2515035F-6993-4BF3-9375-65772F42262BQ46202541-A4E25927-4F04-485F-9196-72025DC9108FQ46204521-7A1A8B33-CA82-4C08-B797-0FF911864164
P2860
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction.
@en
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction.
@nl
type
label
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction.
@en
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction.
@nl
prefLabel
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction.
@en
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction.
@nl
P2093
P1476
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction.
@en
P2093
J A Wagner
J Bauersachs
S K Goparaju
P304
P356
10.1016/S0735-1097(01)01671-0
P407
P577
2001-12-01T00:00:00Z